Categories: HealthPhilippines

Surprisingly, AstraZeneca Withdraw it’s Schedule to Philippines

One of the options Philippines have just updates the country on it’s withdrawal schedule for vaccine. In view of this, the Food and Drug Administration has shared that AstraZeneca cancelled from conducting trials for its coronavirus vaccine candidate.

The local regulators were advised by the British-Swedish drugmaker that they already had enough evidence, which is why they will no longer go ahead with the trials. The FDA Director General Eric Domingo clearly update the changes about this. He clarify that the withdrawal of AstraZeneca to perform clinical trials for its coronavirus vaccine would have no effect on the shot’s regulatory approval.

AstraZeneca’s COVID-19 vaccine was infact on the process before the ethics review board before pulling out of performing trials. In view of this, The Philippines will be left with studies performed by Sinovac Biotech Ltd., Sichuan Clover Biopharmaceuticals, Gamaleya Research Center, and Johnson and Johnson’s vaccine arm Janssen with the departure of AstraZeneca from the conduct of clinical trials

But there’s something interesting since the support of some 30 private companies that pitched in to donate the shots to the government, the Philippines secured 2.6 million doses of the still-unapproved AstraZeneca vaccine.

One of them is Carlito Galvez, the country’s vaccine czar, previously expressed trust in the drugmaker’s development of the jab, citing its reputation for producing quality drugs and vaccines that are used worldwide.

However, AstraZeneca and its affiliate, the University of Oxford, have updated that they are pursuing regulatory approval for their vaccine in the United Kingdom after showing an overall efficacy rate of 70%.

When an initial half-dose then a full dose was given, the rate jumped to 90 percent, comparable to that in rival vaccines by Pfizer/BioNTech and Moderna in growth. Morever, the US scientists, however, point out that the higher efficacy rate came in a smaller trial consisting of individuals aged 55 and that makes them conduct studies even more.

Jasmine C.

Mabuhay! An upcoming Newswriter for the Asian Affairs from the Pearl of the Orient - Philippines. Avid follower of celebrity gossips, fashion news. I got into writing so that my fellow Kababayan will be constantly updated with the latest news.

Recent Posts

Bangchak Reduces the Price of Premium Oil to 5 baht Ahead of Christmas & New Year

BCP (Bangchak Corporation Petroleum Public Company Limited) has announced a New Year gift to the users of BCP Premium oil…

December 23, 2024

Vietnam International Defense Expo 2024

The 2024 Vietnam International Defense Expo was inaugurated by the Prime Minister Pham Minh Chinh on December 19, 2024 and…

December 22, 2024

Shooting concludes: Stranger Things 5 to release on Netflix in 2025

Created by the Duffer Brothers, Stranger Things is one of the most popular sci-fi horror series globally. It is set…

December 21, 2024

China’s Hypersonic Expansion in Asia Raises Alarms for India

According to the US Department of Defense, China has now produced the most sophisticated supply of hypersonic weapons in the…

December 21, 2024

Melaka International Halal Festival 2024

The Melaka International Halal Festival 2024 aims to turn the city as the prime center of the Halal products and…

December 21, 2024

Chunichi Dragons Renews the Contract of Hiroto Takahashi with Annual Salary of 120 million yen

On Saturday, the stalwart of Chunichi Dragons Pitcher, Hiroto Takahashi attended the negotiation for his contract renewal for the next…

December 21, 2024

This website uses cookies.

Read More